New method for imaging genetic material and disease features at a nanoscale level
Official title: Development of ChromEx30 for Nanoscale Imaging of Genetic Organization and Disease Phenotypes
Funded at Panluminate INC. · NIH-11184676 · Data updated 2026-11-12
This study is testing a new imaging technique called ChromEx30 that helps doctors see tiny details in genetic material, which could improve how we understand and treat genetic disorders, ultimately benefiting patients like you.
Quick facts
| Grant type | Sbir 1 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Panluminate INC. NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project start | June 15, 2025 |
| Project end | May 31, 2026 |
| Funding year | 2025 |
| Award (this year) | $404,117 |
| NIH project number | 1R43HG014432-01 |
| Project ID | NIH-11184676 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals with genetic disorders or those at risk of such conditions who may benefit from advanced imaging techniques.
✕Less likely to help
Patients with non-genetic conditions or those who do not have access to the imaging technology may not receive any benefit from this research.
What this research studies
This research focuses on developing a novel imaging technique called ChromEx30, which enhances the visualization of genetic material and disease-related features at a nanoscale resolution. By utilizing a proprietary cell and tissue expansion technology, the method allows for a significant increase in the clarity and detail of biological samples, making it easier to identify specific molecular biomarkers. Patients may benefit from this research as it aims to improve the understanding of genetic disorders and their underlying mechanisms, potentially leading to better diagnostic and therapeutic strategies.
Why it matters
Potential benefit: If successful, this research could lead to improved diagnostic tools and treatment options for genetic disorders.
How similar studies have gone: Other research has shown success with similar imaging techniques, indicating a promising avenue for advancements in genetic research.
Where this research is happening
-
Panluminate INC.
New Haven, United States Active
Researchers
- Principal investigator: M'saad, Ons — Panluminate INC.
- Study coordinator: M'saad, Ons
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.